News • Public health

Lax salt rules linked to increase of CVD and cancer

More cancer, more cardiovascular disease: The relaxation of UK industry regulation of salt content in food was – to put it lightly – a very bad idea, say researchers from Imperial College London and the University of Liverpool.

wooden salt shaker
Careful with that.

Image by 955169 from Pixabay

They have linked the change in regulation with 9,900 additional cases of cardiovascular disease (CVD), and 1,500 cases of stomach cancer. The researchers analysed the salt intake of the population in England over thirteen years to compare the effect of changes in regulations on how much salt manufacturers can use in their products. The team, who published their work in the Journal of Epidemiology and Community Health, found that since the regulations on industry had been relaxed in 2011, the national decline in salt intake has stalled. Prior to 2011, salt intake was falling annually by 0.2g a day for men, and 0.12g a day for women. However, post 2011, when the regulations were relaxed, annual declines slowed to 0.11g per day for men, and 0.07g per day for women.

However, in 2011 this policy was replaced by the Public Health Responsibility Deal. Here, the food industry set their own targets as part of voluntary pledges they could sign-up to and they were asked to report their progress to the Department of Health. But the newer system lacked robust and independent target setting, monitoring, and enforcement, argues Dr Anthony Laverty, lead author of the research from Imperial’s School of Public Health: “Evidence from around the world is now showing that mandatory approaches are much more effective than self-regulation by industry in reducing the amount of salt and sugar in our diet.”

Salt intake has been linked to an increase in cardiovascular disease – including heart attacks and stroke – as well as to an increased risk of stomach cancers. Adults are advised to eat no more than 6g (one teaspoon) a day, or 3g a day for children. However, adults in England are thought to eat an average of 8g a day and two in three people consume too much salt – with most of this coming from processed foods such as bread, processed meats and ready meals.

Recommended article

Photo

News • Sodium consumption

Daily salt intake: How much is too much for our heart?

New research shows that for the vast majority of individuals, sodium consumption does not increase health risks except for those who eat more than five grams a day, the equivalent of 2.5 teaspoons of salt. Fewer than five per cent of individuals in developed countries exceed that level. The large, international study also shows that even for those individuals there is good news. However, the…

Three-quarters of salt in our diet is hidden in processed food such as bread, ready meals and soups

Martin O’Flaherty

The team estimated the amount of cases of cardiovascular disease and stomach cancer associated with the slowing in the reductions in daily salt intake seen under the change of policy in 2011 to 2017. They found that an extra 9,900 cases of cardiovascular disease, and 1,500 cases of stomach cancer could be attributable to the change of policy from the independent FSA-led policy to the Responsibility Deal. The researchers also found this additional disease burden hit the UK economy, as well as the nation’s health. They estimated that relaxing the food industry regulations cost the economy around £160millon from 2011-2017. That included healthcare costs of extra heart attacks, strokes and cancer cases, and the loss of productivity due to workplace absences. 

Without urgent and decisive action, the researchers predict even more avoidable heart attacks, strokes and cancer cases. Using a computer model, the team estimated future cases of cardiovascular disease and stomach cancer if the average reduction in salt intake continues at the current rate. They estimated an additional 26,000 of cardiovascular disease, and 3,800 cases of stomach cancer between 2019 and 2025. This could cost an additional £960 million to the economy over the next 6 years.

The team used data from the National Diet and Nutrition Survey and national salt surveys, conducted 2000 – 2013. These surveys included urine analysis of over 3,000 people, which showed in detail how much salt they were eating in their diet every day, and acted as a representative sample of the population. The team acknowledge that although the data has limitations, the findings confirm previous criticisms that the Responsibility Deal was not an effective tool to improve the nation’s health.

Professor Martin O’Flaherty, co-author of the study from the University of Liverpool added: “We are eating too much salt. Previous research has shown three-quarters of salt in our diet is hidden in processed food such as bread, ready meals and soups. The FSA approach was one of the most robust strategies internationally. Our research shows that we now need an equally robust mandatory programme to accelerate salt intake reduction. This will require clear targets and penalties to ensure the food industry reduce salt content in foods. Softer, voluntary measures could generate additional heart attacks, strokes and cancer cases.”


Source: Imperial College London

20.07.2019

Related articles

Photo

News • Adaptive mutability

How bowel cancer flips the switch to avoid immune detection

Why does the immune system sometimes fail to control the development of bowel cancer? UK and Dutch researchers discovered how cancer cells use a genetic "switch" to evade detection.

Photo

News • Opportunity for new treatment approaches

Atherosclerosis and cancer share surprising similarities, study finds

In cancer, cell deterioration can drive progression. A similar process happens in artherosclerosis, new research reveals. This finding could lead to new ways of combatting disease-causing plaque.

Photo

News • Tumor organoid platform

Personalized 3D bioprinting to advance gastric cancer treatment

Using 3D bioprinting to accurately replicate the biological environment surrounding gastric cancer cells, researchers predicted a patient’s response to anticancer drugs during the preclinical stage.

Related products

Subscribe to Newsletter